中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | 4-(4,6-Isopropyliden-cyclohexenyl)-butyraldehyd | 474070-41-2 | C13H20O | 192.301 |
—— | 4-((1R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)butan-1-ol | 461417-84-5 | C13H22O | 194.317 |
—— | beta-pinene | 19902-08-0 | C10H16 | 136.237 |
中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | (1R,5S)-2-[4-(2-methoxypropan-2-ylperoxy)butyl]-6,6-dimethylbicyclo[3.1.1]hept-2-ene | 474070-45-6 | C17H30O3 | 282.423 |
Respiratory syncytial virus (RSV) causes annual epidemics of respiratory infection. Usually harmless to adults, the RSV infection can be dangerous to children under 3 years of age and elderly people over 65 years of age, often causing serious problems, even death. At present, there are no vaccines and specific chemotherapeutic agents for the treatment of this disease, so the search for low-molecular weight compounds to combat RSV is a challenge. In this work, we have shown, for the first time, that monoterpene-substituted arylcoumarins are efficient RSV replication inhibitors at low micromolar concentrations. The most active compound has a selectivity index of about 200 and acts most effectively at the early stages of infection. The F protein of RSV is a potential target for these compounds, which is also confirmed by molecular docking and molecular dynamics simulation data.
Respiratory syncytial virus (RSV) is a critical cause of infant mortality. However, there are no vaccines and adequate drugs for its treatment. We showed, for the first time, that O-linked coumarin–monoterpene conjugates are effective RSV inhibitors. The most potent compounds are active against both RSV serotypes, A and B. According to the results of the time-of-addition experiment, the conjugates act at the early stages of virus cycle. Based on molecular modelling data, RSV F protein may be considered as a possible target.